BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 4417187)

  • 1. [Use of a subcutaneously administered heparin preparation].
    Stosiek U; Grumbrecht C
    Med Welt; 1974 Apr; 25(17):765-8. PubMed ID: 4417187
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experiences with Calciparin, a new subcutaneously injectable heparin preparation].
    Sessner HH; Brockhaus W; Kunzmann G; Stingl J
    Med Welt; 1971 Jan; 5():187-91. PubMed ID: 5546024
    [No Abstract]   [Full Text] [Related]  

  • 3. [Stability of the anticoagulating effect of calcium and sodium heparin, injected subcutaneously].
    Langer B; Pinto WC; Maia RA; Kwang WT; Leão LE
    AMB Rev Assoc Med Bras; 1978 Apr; 24(4):121-3. PubMed ID: 308244
    [No Abstract]   [Full Text] [Related]  

  • 4. In vivo studies on the inhibition of coagulation by fractionated heparin and by a heparin analogue. I. Effects of heparin fractions.
    Schmitz-Huebner U; Balleisen L; Asbeck F; van de Loo J
    Thromb Haemost; 1981 Oct; 46(3):612-6. PubMed ID: 7031982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of subcutaneous depot heparin on certain coagulation parameters (preliminary report)].
    Petö I; Blaskó G; Sas G
    Orv Hetil; 1981 Jan; 122(3):145-6. PubMed ID: 7220045
    [No Abstract]   [Full Text] [Related]  

  • 6. [Mechanism of action of low doses of subcutaneous heparin (author's transl)].
    Duckert F
    Ther Umsch; 1977 May; 34(5):334-7. PubMed ID: 867313
    [No Abstract]   [Full Text] [Related]  

  • 7. [Low dosage of heparin. Theoretical and practical evaluation].
    Gormsen J; Feddersen C; Clausen NT
    Ugeskr Laeger; 1974 Apr; 136(16):865-70. PubMed ID: 4825561
    [No Abstract]   [Full Text] [Related]  

  • 8. [Thrombosis and heart infarct prevention using subcutaneous heparin therapy].
    Steger W
    Fortschr Med; 1974 Jan; 92(2):76-9. PubMed ID: 4818252
    [No Abstract]   [Full Text] [Related]  

  • 9. Low-dose heparin therapy.
    Chamberlain SL
    Am J Nurs; 1980 Jun; 80(6):1115-7. PubMed ID: 6446861
    [No Abstract]   [Full Text] [Related]  

  • 10. Heparin therapy by continuous intravenous infusion.
    Swanson M; Cacace L
    Am J Hosp Pharm; 1971 Oct; 28(10):792-5. PubMed ID: 5125174
    [No Abstract]   [Full Text] [Related]  

  • 11. Activated coagulation time in monitoring heparinized dogs.
    Green RA
    Am J Vet Res; 1980 Nov; 41(11):1793-7. PubMed ID: 7212408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the effect of subcutaneous heparin on blood coagulability and blood lipids in diabetic patients].
    Ghanem MH; Tawfik S; Guirgis FK; el-Sawy M
    Therapeutique; 1971 May; 47(5):473-6. PubMed ID: 5562482
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anticoagulant treatment with heparin].
    Langer B; Wolosker M; Albers MT
    Rev Paul Med; 1982; 99(1):31-2. PubMed ID: 7146741
    [No Abstract]   [Full Text] [Related]  

  • 14. In vivo studies on the inhibition of coagulation by fractionated heparin and by a heparin analogue. II. Effects of a heparin analogue.
    Schmitz-Huebner U; Asbeck F; van de Loo J
    Thromb Haemost; 1981 Oct; 46(3):617-20. PubMed ID: 6797091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of pentosan polysulphate and heparin. II: Effects of subcutaneous injection.
    Fischer AM; Merton RE; Marsh NA; Williams S; Gaffney PJ; Barrowcliffe TW; Thomas DP
    Thromb Haemost; 1982 Apr; 47(2):109-13. PubMed ID: 6179183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of various doses and various applications of heparin on the fat metabolism and on blood coagulation.
    Losonczy H; Nagy I
    Wien Klin Wochenschr; 1984 Dec; 96(24):885-9. PubMed ID: 6528619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of some blood clotting indices and free fatty acids following single subcutaneous 50 mg dose of heparin].
    Malanowicz W; Latallo ZS; Stanislawska J
    Pol Arch Med Wewn; 1974 Oct; 52(4):375-81. PubMed ID: 4418984
    [No Abstract]   [Full Text] [Related]  

  • 18. Activated partial thromboplastin time and activated coagulation time in monitoring heparinized cats.
    Greene CE; Meriwether E
    Am J Vet Res; 1982 Aug; 43(8):1473-7. PubMed ID: 7103231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacologic action of "low doses" or "small doses" of heparin administered subcutaneously].
    Raby C; Bertrand H
    Nouv Presse Med; 1978 Aug 26-Sep 2; 7(28):2476. PubMed ID: 693287
    [No Abstract]   [Full Text] [Related]  

  • 20. [Correction of disorders of hemostasis in children with suppurative-infectious diseases].
    Dmitriev VV; Vakul'chik VG
    Khirurgiia (Mosk); 1984 Jul; (7):89-92. PubMed ID: 6482227
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.